T1	CHEM 88 98	remdesivir
#1	AnnotatorNotes T1	C4726677; remdesivir; Organic Chemical · Pharmacologic Substance
T2	CHEM 68 79	medicamento
#2	AnnotatorNotes T2	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T3	PROC 114 151	evaluar la seguridad y la efectividad
T4	CHEM 156 167	medicamento
#3	AnnotatorNotes T4	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T5	PROC 174 185	tratamiento
#4	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	DISO 203 246	enfermedad moderada por el coronavirus 2019
T7	PROC 325 355	Estudio de Fase 3 Aleatorizado
T8	PROC 361 381	Evaluar la Seguridad
#5	AnnotatorNotes T8	C1705187; Safety Study; Research Activity
T9	CHEM 410 420	Remdesivir
#6	AnnotatorNotes T9	C4726677; remdesivir; Organic Chemical · Pharmacologic Substance
T10	DISO 452 486	infección moderada por el COVID-19
T11	DISO 556 590	Enfermedad por el Coronavirus 2019
#7	AnnotatorNotes T11	C5203670; COVID19 (disease); Disease or Syndrome
T12	PROC 855 869	procedimientos
#8	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T13	PROC 1048 1062	procedimientos
#9	AnnotatorNotes T13	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T14	DISO 1273 1300	Infección por el SARS-CoV-2
#10	AnnotatorNotes T14	C5203670; COVID19 (disease); Disease or Syndrome
T15	DISO 248 256	COVID-19
#11	AnnotatorNotes T15	C5203670; COVID19 (disease); Disease or Syndrome
T16	DISO 592 600	COVID-19
#12	AnnotatorNotes T16	C5203670; COVID19 (disease); Disease or Syndrome
T17	DISO 1421 1429	COVID-19
#13	AnnotatorNotes T17	C5203670; COVID19 (disease); Disease or Syndrome
T18	PROC 1346 1360	aleatorización
#14	AnnotatorNotes T18	C0034656; Randomization; Research Activity
T19	PROC 1364 1379	Hospitalización
#15	AnnotatorNotes T19	C0019993; Hospitalization; Health Care Activity
T20	PROC 1395 1412	asistencia médica
T21	DISO 1514 1536	infiltrados pulmonares
#16	AnnotatorNotes T21	C0277877; Radiologic infiltrate of lung; Finding
T22	PROC 999 1025	consentimiento por escrito
#17	AnnotatorNotes T22	C0811746; Obtain written consent; Health Care Activity
T23	PROC 1663 1686	métodos anticonceptivos
#18	AnnotatorNotes T23	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T24	PROC 670 706	consentimiento informado por escrito
#19	AnnotatorNotes T24	C0811741; Obtain informed written consent; Health Care Activity
T25	PROC 1707 1716	protocolo
#20	AnnotatorNotes T25	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T26	PROC 1760 1769	Protocolo
#21	AnnotatorNotes T26	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T27	PROC 1828 1842	ensayo clínico
#22	AnnotatorNotes T27	C0008976; Clinical Trials; Research Activity
T28	PROC 1846 1857	tratamiento
#23	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	CHEM 1865 1885	fármaco experimental
#24	AnnotatorNotes T29	C0304229; Experimental drug; Pharmacologic Substance
T30	PROC 1908 1932	Tratamiento concomitante
#25	AnnotatorNotes T30	C1707479; Concomitant Therapy; Therapeutic or Preventive Procedure
T31	CHEM 1943 1983	fármacos con actividad antiviral directa
#26	AnnotatorNotes T31	C3653501; DIRECT ACTING ANTIVIRALS; Pharmacologic Substance
T32	CHEM 422 429	GS-5734
#27	AnnotatorNotes T32	C4279131; GS-5734; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T33	DISO 1896 1904	COVID-19
#28	AnnotatorNotes T33	C5203670; COVID19 (disease); Disease or Syndrome
T34	CHEM 2068 2075	fármaco
#29	AnnotatorNotes T34	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T35	PROC 2105 2125	ventilación mecánica
#30	AnnotatorNotes T35	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T36	PROC 2177 2203	Aclaramiento de creatinina
#31	AnnotatorNotes T36	C0373595; Creatinine clearance measurement; Laboratory Procedure
T37	PROC 2365 2383	Prueba de embarazo
#32	AnnotatorNotes T37	C0032976; Pregnancy Tests; Diagnostic Procedure
T38	PROC 2303 2322	fórmula de Schwartz
#33	AnnotatorNotes T38	C1980037; Creatinine-based formula (Schwartz); Laboratory Procedure
T39	PROC 2409 2418	Protocolo
#34	AnnotatorNotes T39	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T40	DISO 2444 2461	Hipersensibilidad
#35	AnnotatorNotes T40	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T41	CHEM 2474 2481	fármaco
#36	AnnotatorNotes T41	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T42	PROC 2225 2251	fórmula de Cockcroft-Gault
#37	AnnotatorNotes T42	C2711451; Estimation of creatinine clearance by Cockcroft-Gault formula; Laboratory Procedure
T43	CHEM 2499 2510	metabolitos
#38	AnnotatorNotes T43	C0870883; Metabolite; Biologically Active Substance
T44	CHEM 2517 2528	excipientes
#39	AnnotatorNotes T44	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T45	PROC 278 303	tratamiento de referencia
T46	PROC 509 534	tratamiento de referencia
T47	PROC 1321 1324	PCR
#40	AnnotatorNotes T47	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T48	PROC 1435 1439	SpO2
#41	AnnotatorNotes T48	C0428179; Measurement of oxygen saturation at periphery; Laboratory Procedure
T49	ANAT 1526 1536	pulmonares
#42	AnnotatorNotes T49	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T50	CHEM 100 107	GS-5734
#43	AnnotatorNotes T50	C4279131; GS-5734; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T51	PROC 2049 2075	administración del fármaco
#44	AnnotatorNotes T51	C3469597; Administration of medication; Therapeutic or Preventive Procedure
T52	PROC 2153 2156	ALT
#45	AnnotatorNotes T52	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T53	PROC 2160 2163	AST
#46	AnnotatorNotes T53	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T54	CHEM 2193 2203	creatinina
#47	AnnotatorNotes T54	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T55	Date 12 16	2020
T56	LIVB 189 198	pacientes
#48	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	LIVB 230 246	coronavirus 2019
#49	AnnotatorNotes T57	C5203676; SARS-CoV-2; Virus
T59	LIVB 574 590	Coronavirus 2019
#50	AnnotatorNotes T59	C5203676; SARS-CoV-2; Virus
T61	Age 723 731	≥18 años
T62	Age 769 783	≥12 a <18 años
T63	Age 914 933	≥12 años y <18 años
T65	LIVB 963 968	padre
#51	AnnotatorNotes T65	C0015671; Father (person); Family Group | C0030551; parent; Family Group
T66	Age 1084 1093	≥ 18 años
T67	Age 1125 1139	≥12 y <18 años
T68	Duration 1325 1333	≤ 4 días
T69	LIVB 1558 1565	mujeres
#52	AnnotatorNotes T69	C0043210; Woman; Population Group
T70	PHYS 1583 1591	procrear
#53	AnnotatorNotes T70	C0035150; Reproduction; Organism Function
T72	LIVB 2009 2019	SARS-CoV-2
#54	AnnotatorNotes T72	C5203676; SARS-CoV-2; Virus
T73	Duration 2023 2035	las 24 horas
T75	Age 2274 2283	≥ 18 años
T76	Date 2295 2299	1976
T77	Age 2342 2360	menores de 18 años
T78	LIVB 2423 2440	Mujeres lactantes
#55	AnnotatorNotes T78	C0043210; Woman; Population Group + C4316174; Patients who are breastfeeding; Patient or Disabled Group
T81	PHYS 2375 2383	embarazo
#56	AnnotatorNotes T81	C0032961; Pregnancy; Organism Function
T58	LIVB 971 982	tutor legal
#57	AnnotatorNotes T58	C0023226; Legal Guardians; Population Group
T60	LIVB 1544 1551	varones
#58	AnnotatorNotes T60	C0025266; Male population group; Population Group
T64	PROC 1144 1148	peso
#59	AnnotatorNotes T64	C2985231; Body Weight Measurement; Diagnostic Procedure
T71	LIVB 434 447	Participantes
#60	AnnotatorNotes T71	C4554048; Study Participant; Population Group
T74	LIVB 897 910	participantes
#61	AnnotatorNotes T74	C4554048; Study Participant; Population Group
T79	LIVB 752 765	participantes
#62	AnnotatorNotes T79	C4554048; Study Participant; Population Group
T80	LIVB 2257 2270	participantes
#63	AnnotatorNotes T80	C4554048; Study Participant; Population Group
T82	LIVB 2328 2341	participantes
#64	AnnotatorNotes T82	C4554048; Study Participant; Population Group
T83	LIVB 1290 1300	SARS-CoV-2
#65	AnnotatorNotes T83	C5203676; SARS-CoV-2; Virus
T84	LIVB 708 719	partipantes
#66	AnnotatorNotes T84	C4554048; Study Participant; Population Group
T85	PHYS 2431 2440	lactantes
#67	AnnotatorNotes T85	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
A1	Status T40 History_of
#68	AnnotatorNotes T7	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity
R1	Experiences Arg1:T56 Arg2:T5	
R2	Used_for Arg1:T4 Arg2:T5	
R3	Experiences Arg1:T56 Arg2:T2	
R4	Experiences Arg1:T56 Arg2:T1	
R5	Experiences Arg1:T56 Arg2:T50	
R6	Experiences Arg1:T56 Arg2:T6	
R7	Causes Arg1:T57 Arg2:T6	
R8	Causes Arg1:T57 Arg2:T15	
R9	Experiences Arg1:T56 Arg2:T15	
R10	Experiences Arg1:T56 Arg2:T45	
R11	Experiences Arg1:T71 Arg2:T32	
R12	Experiences Arg1:T71 Arg2:T9	
R13	Experiences Arg1:T71 Arg2:T10	
R14	Experiences Arg1:T71 Arg2:T46	
R15	Causes Arg1:T59 Arg2:T11	
R16	Causes Arg1:T59 Arg2:T16	
R17	Has_Age Arg1:T84 Arg2:T61	
R18	Has_Age Arg1:T79 Arg2:T62	
R19	Before Arg1:T24 Arg2:T12	
R20	Experiences Arg1:T84 Arg2:T12	
R21	Experiences Arg1:T79 Arg2:T12	
R22	Has_Age Arg1:T74 Arg2:T63	
R23	Before Arg1:T22 Arg2:T13	
T86	Result_or_Value 1149 1172	igual o superior a 40kg
R24	Has_Result_or_Value Arg1:T64 Arg2:T86	
R25	Causes Arg1:T83 Arg2:T14	
R26	Overlap Arg1:T47 Arg2:T68	
R27	Before Arg1:T47 Arg2:T18	
T87	Result_or_Value 1440 1445	> 94%
R28	Has_Result_or_Value Arg1:T48 Arg2:T87	
R29	Location_of Arg1:T49 Arg2:T21	
#69	AnnotatorNotes T20	C0496675; Medical care; Health Care Activity
R30	Experiences Arg1:T69 Arg2:T70	
R31	Experiences Arg1:T60 Arg2:T70	
T88	Observation 1606 1631	relaciones heterosexuales
#70	AnnotatorNotes T88	C0556476; Heterosexual relationship; Finding
R32	Experiences Arg1:T60 Arg2:T88	
R33	Experiences Arg1:T69 Arg2:T88	
R34	Experiences Arg1:T69 Arg2:T23	
R35	Experiences Arg1:T60 Arg2:T23	
T89	Observation 1799 1842	Participar en cualquier otro ensayo clínico
R36	Used_for Arg1:T29 Arg2:T28	
R37	Used_for Arg1:T31 Arg2:T30	
R38	Has_Duration_or_Interval Arg1:T31 Arg2:T73	
R39	Before Arg1:T30 Arg2:T51	
R40	Used_for Arg1:T34 Arg2:T51	
T90	PROC 2140 2149	selección
#71	AnnotatorNotes T90	C0242802; Patient Selection; Research Activity | C1710477; Trial Screening; Research Activity
R41	Overlap Arg1:T35 Arg2:T90	
T91	Result_or_Value 2164 2173	> 5 x LSN
R42	Has_Result_or_Value Arg1:T53 Arg2:T91	
R43	Has_Result_or_Value Arg1:T52 Arg2:T91	
T92	Result_or_Value 2204 2215	< 50 mL/min
R44	Has_Result_or_Value Arg1:T36 Arg2:T92	
R45	Experiences Arg1:T80 Arg2:T36	
R47	Has_Age Arg1:T80 Arg2:T75	
R49	Has_Age Arg1:T82 Arg2:T77	
R50	Experiences Arg1:T82 Arg2:T36	
T93	Result_or_Value 2384 2392	positiva
#72	AnnotatorNotes T93	C1446409; Positive; Finding
R51	Has_Result_or_Value Arg1:T37 Arg2:T93	
R52	Experiences Arg1:T78 Arg2:T85	
R53	Causes Arg1:T41 Arg2:T40	
R54	Causes Arg1:T43 Arg2:T40	
R55	Causes Arg1:T44 Arg2:T40	
T94	Quantifier_or_Qualifier 1446 1463	con aire ambiente
R56	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T94	
T95	PROC 1478 1487	selección
#73	AnnotatorNotes T95	C0242802; Patient Selection; Research Activity | C1710477; Trial Screening; Research Activity
R57	Overlap Arg1:T48 Arg2:T95	
T96	Observation 738 750	asentimiento
R59	Before Arg1:T96 Arg2:T12	
T97	Observation 1491 1510	Signos radiológicos
R60	Used_for Arg1:T50 Arg2:T5	
R61	Used_for Arg1:T1 Arg2:T5	
R62	Used_for Arg1:T2 Arg2:T5	
T98	Observation 644 653	capacidad
#74	AnnotatorNotes T98	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R63	Before Arg1:T98 Arg2:T24	
T99	Observation 949 958	capacidad
#75	AnnotatorNotes T99	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R65	Before Arg1:T99 Arg2:T22	
R68	Overlap Arg1:T88 Arg2:T23	
R69	Overlap Arg1:T97 Arg2:T21	
R46	Overlap Arg1:T64 Arg2:T67	
#76	AnnotatorNotes T45	C2936643; Standard of Care; Health Care Activity
#77	AnnotatorNotes T46	C2936643; Standard of Care; Health Care Activity
#78	AnnotatorNotes T3	C0511730; Identify product efficacy and safety issues; Health Care Activity
#79	AnnotatorNotes T96	C1302239; Patient consented to clinical trial; Finding (?)
#80	AnnotatorNotes T6	C5708321; Moderate COVID-19 Infection; Disease or Syndrome
#81	AnnotatorNotes T10	C5708321; Moderate COVID-19 Infection; Disease or Syndrome
A2	Experiencer T82 Patient
A3	Experiencer T80 Patient
A4	Experiencer T78 Patient
A5	Experiencer T56 Patient
A6	Experiencer T71 Patient
A7	Experiencer T84 Patient
A8	Experiencer T79 Patient
A9	Experiencer T74 Patient
A10	Experiencer T65 Family_member
A11	Experiencer T58 Other
A12	Experiencer T60 Patient
A13	Experiencer T69 Patient
A14	Assertion T63 Hypothetical
